Target intelligence / Profile preview

Adaptor-related protein complex 2 subunit beta 1 (AP2B1)

Target
AP2B1
Molecular classification
Vesicle coat component, Adaptor protein complex subunit
01

Overview

Adaptor-related protein complex 2 subunit beta 1 (AP2B1) is a large subunit of the heterotetrameric AP-2 adaptor complex, which functions as a crucial mediator of clathrin-mediated endocytosis at the plasma membrane[1][2][3][5]. The AP-2 complex acts as a bridge linking clathrin to selected cargo proteins, participating centrally in vesicle formation, cargo selection, and receptor-mediated endocytosis[1][2][3]. AP2B1 specifically contributes to clathrin lattice assembly and provides a scaffold for recruiting endocytic accessory proteins[1][2][3]. Its activity is essential for processes such as synaptic vesicle recycling, and disturbances in AP2B1 or the AP-2 complex have been implicated in neurodevelopmental and neurodegenerative disorders, as well as various pathological states where vesicle trafficking is disrupted[4][5][3]. It is not classified as a therapeutic target, receptor, enzyme, or transporter, but is fundamental for cellular vesicle trafficking and membrane protein sorting[1][2][3].

Other names
AP-2 complex subunit betaAP2B1ADTB2CLAPB1AP105BBeta-2-adaptinBeta-adaptinClathrin assembly protein complex 2 beta large chainPlasma membrane adaptor HA2/AP2 adaptin beta subunitAdaptor protein complex AP-2 subunit betaAdapter-related protein complex 2 beta subunit
02

Biological functions

Clathrin-mediated endocytosisCargo selection in vesicular traffickingSynaptic vesicle membrane recyclingProtein transport via vesiclesReceptor-mediated endocytosisRegulation of post-endocytic traffickingScaffold for endocytic accessory proteins
03

Disease associations

Intellectual developmental disorderAtaxia-telangiectasiaSynucleinopathy (association with neurodegenerative diseases such as Alzheimer's Disease)Cancer (biomarker studies)Inflammation (biomarker studies)Neurological diseases (biomarker studies)
04

Biomarkers

Potential biomarker in plasma/serum for neurological, inflammatory, cardiovascular, and autoimmune disease, as well as cancer[2]

Beyond the preview

Go deeper on Adaptor-related protein complex 2 subunit beta 1 (AP2B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adaptor-related protein complex 2 subunit beta 1 (AP2B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call